Quarry LP’s Lifecore Biomedical LFCR Stock Holding History

Quarry LP’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,400	Closed	-$11.5K	–	1884
2025 Q4	$11.5K	Sell	1,400 -2,383	-63%	-$17.6K	﹤0.01%	1328
2025 Q3	$27.8K	Buy	+3,783	New	+$28.6K	0.01%	1203

Other funds holding LFCR

22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Grizzlyrock Capital Chicago, Illinois $143M AUM 6.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quarry LP's LFCR Position: Q1 2026 in Review

Quarry LP sold out of Lifecore Biomedical (LFCR) in Q1 2026, closing a stake of 1,400 shares — an estimated $11.5K sold.

Quarry LP first reported a position in LFCR in Q3 2025 and held it in 2 quarters. The position peaked at $27.8K in Q3 2025. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

Quarry LP reported no remaining Lifecore Biomedical position as of Q1 2026 after selling out during the quarter.
Quarry LP sold 1,400 Lifecore Biomedical shares in Q1 2026, an estimated $11.5K.
Quarry LP first reported a position in Lifecore Biomedical in Q3 2025 and held it in 2 quarters.
Quarry LP's Lifecore Biomedical position peaked at $27.8K in Q3 2025.
105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.